B a c k g round: Various reports showed the efficacy of Narrow Band UVB (311-313 nm) and excimer laser (308 nm) in the treatment of psoriasis. Objective: To prove the efficacy of light produced by xenon-cloride excimer at 308 nm (Monochromatic Excimer Light, MEL) in the treatment of stable forms of localized plaque psoriasis. Patients and methods: This study was an open trial with 152 patients affected with stable mild to moderate plaque psoriasis (PASI score between 4 and 12) were t reated with a weekly session of MEL A total number of 6-16 sessions was p e rformed with a dose increase according to patient phototype and re s p o n s e . Results: 152 patients were enrolled in the study and 149 completed the pro t o c o l . Patients were followed up every two weeks, 57 patients for one-year and 92 patients for 6 months. After 4 months there was complete remission in 87 patients, partial remission in 37 and moderate improvement in 25 patients. Conclusions: These pre l i m i n a ry results suggest that MEL can be considered as a valid option for treatment of selected forms of localized plaque psoriasis.
Monocromatic excimer Light treatment of psoriasis / Nistico', S; Saraceno, R; Schipani, C; Costanzo, A; Chimenti, S. - In: JOURNAL OF PLASTIC DERMATOLOGY. - ISSN 2035-0686. - 4:3(2008), pp. 263-266.
Monocromatic excimer Light treatment of psoriasis
NISTICO' S;
2008
Abstract
B a c k g round: Various reports showed the efficacy of Narrow Band UVB (311-313 nm) and excimer laser (308 nm) in the treatment of psoriasis. Objective: To prove the efficacy of light produced by xenon-cloride excimer at 308 nm (Monochromatic Excimer Light, MEL) in the treatment of stable forms of localized plaque psoriasis. Patients and methods: This study was an open trial with 152 patients affected with stable mild to moderate plaque psoriasis (PASI score between 4 and 12) were t reated with a weekly session of MEL A total number of 6-16 sessions was p e rformed with a dose increase according to patient phototype and re s p o n s e . Results: 152 patients were enrolled in the study and 149 completed the pro t o c o l . Patients were followed up every two weeks, 57 patients for one-year and 92 patients for 6 months. After 4 months there was complete remission in 87 patients, partial remission in 37 and moderate improvement in 25 patients. Conclusions: These pre l i m i n a ry results suggest that MEL can be considered as a valid option for treatment of selected forms of localized plaque psoriasis.File | Dimensione | Formato | |
---|---|---|---|
Jisplad 2008-MEL PSO Nisticò.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
211.71 kB
Formato
Adobe PDF
|
211.71 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.